BDHAX
Price
$9.10
Change
+$0.01 (+0.11%)
Updated
Jun 2 closing price
Net Assets
1.6B
CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
Interact to see
Advertisement

BDHAX vs CIMCX

Header iconBDHAX vs CIMCX Comparison
Open Charts BDHAX vs CIMCXBanner chart's image
BDHAX vs CIMCX Comparison Chart in %
View a ticker or compare two or three
VS
BDHAX vs. CIMCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDHAX is a Buy and CIMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. BDHAX (1.6B). BDHAX pays higher dividends than CIMCX: BDHAX (7.34) vs CIMCX (2.73). BDHAX was incepted earlier than CIMCX: BDHAX (12 years) vs CIMCX (24 years). CIMCX (1.35) is less costly to investors than BDHAX (1.09). BDHAX is a more actively managed with annual turnover of: 148.00 vs. CIMCX (65.00). CIMCX has a lower initial minimum investment than BDHAX: CIMCX (250) vs BDHAX (1000). BDHAX annual gain was more profitable for investors over the last year : 13.42 vs. CIMCX (8.06). BDHAX return over 5 years is better than : 23.39 vs. CIMCX (20.12).
BDHAXCIMCXBDHAX / CIMCX
Total Expense Ratio0.931.3569%
Annual Report Gross Expense Ratio1.091.3581%
Fund Existence12 years24 years-
Gain YTD4.8745.65486%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B147B1%
Annual Yield % from dividends7.342.73269%
Returns for 1 year13.428.06167%
Returns for 3 years40.1633.07121%
Returns for 5 years23.3920.12116%
Returns for 10 years83.6567.70124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C